Viemed Healthcare, Inc. (NASDAQ:VMD) Short Interest Up 25.2% in March

Viemed Healthcare, Inc. (NASDAQ:VMD) saw a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 398,300 shares, an increase of 25.2% from the March 15th total of 318,100 shares. Approximately 1.2% of the shares of the company are short sold. Based on an average daily volume of 114,100 shares, the short-interest ratio is presently 3.5 days.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Price T Rowe Associates Inc. MD boosted its position in shares of Viemed Healthcare by 18.1% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,005 shares of the company’s stock valued at $105,000 after acquiring an additional 1,997 shares during the period. LPL Financial LLC grew its position in Viemed Healthcare by 1.6% in the 4th quarter. LPL Financial LLC now owns 194,690 shares of the company’s stock worth $1,561,000 after purchasing an additional 3,000 shares during the last quarter. Martingale Asset Management L P increased its holdings in shares of Viemed Healthcare by 11.0% during the 4th quarter. Martingale Asset Management L P now owns 34,836 shares of the company’s stock worth $279,000 after purchasing an additional 3,451 shares during the period. Bard Associates Inc. raised its position in shares of Viemed Healthcare by 1.3% during the fourth quarter. Bard Associates Inc. now owns 349,526 shares of the company’s stock valued at $2,803,000 after buying an additional 4,474 shares during the last quarter. Finally, R Squared Ltd bought a new stake in shares of Viemed Healthcare in the fourth quarter valued at about $41,000. Institutional investors and hedge funds own 74.24% of the company’s stock.

Viemed Healthcare Trading Down 0.3 %

NASDAQ:VMD opened at $6.61 on Tuesday. The company has a quick ratio of 1.19, a current ratio of 1.31 and a debt-to-equity ratio of 0.03. The company’s 50 day moving average is $7.30 and its 200-day moving average is $8.09. The firm has a market cap of $261.24 million, a price-to-earnings ratio of 24.48 and a beta of 1.64. Viemed Healthcare has a 12 month low of $6.21 and a 12 month high of $9.81.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.